A genetically engineered probiotic bacterium, designed to release a glucose-lowering hormone in response to high blood sugar, performed similarly to Ozempic in animal studies. It is expected to be available in the US as a health supplement within two years.
O mercado wellness brasileiro ganha novas bebidas funcionais como cerveja com proteína, espuma de café proteica e refrigerante com fibras. Especialistas debatem os benefícios nutricionais reais, a relação de custo-benefício e o apelo de marketing dessas inovações.
Researchers report a rising incidence of type 2 diabetes among adults under 40, particularly young women in England and Germany, driven by lifestyle factors and complicated by underdiagnosis.
A study published in Neurology finds that maintaining normal blood pressure, avoiding type 2 diabetes, and not smoking between ages 45-65 can add nearly 13 dementia-free years, with significant gender and racial differences observed.
Eli Lilly erhöht Umsatzprognose für 2026 auf 85-87 Milliarden Dollar dank starker Nachfrage nach Medikamenten wie Mounjaro und Zepbound.
Elcella and Calocurb, natural supplements developed in the UK and NZ, respectively, aim to mimic synthetic diabetes medications' weight-loss effects by stimulating 'fullness hormones' GLP-1 and PYY, with promising but limited human trial results.
WuXi AppTec reported a 33.7 per cent rise in H1 net profit to 11.08 billion yuan, beating expectations driven by strong demand for weight-loss and diabetes drugs and US growth.
Wuxi AppTec, Asia's largest contract pharmaceutical research provider, reported H1 net income of 11.08 billion yuan, surpassing market estimates. This strong performance was driven by robust demand for weight-loss and diabetes drugs, alongside significant growth in its US business.
Maria Heloíse, bebê de dois meses, foi diagnosticada com cardiopatia congênita ainda na gestação. Nascida em São Paulo devido à falta de estrutura no Acre, ela passou por um cateterismo cardíaco para abrir uma artéria pulmonar e aguarda cirurgia corretiva definitiva em 2027.
Duas farmácias em Maceió foram alvo de roubos em janeiro e maio, resultando no furto de medicamentos injetáveis Mounjaro, avaliados em R$ 150 mil. A Polícia Civil, através da DERC, investiga uma quadrilha especializada, identificando um ex-funcionário e outros suspeitos, e prendeu o motorista de fuga.
Australia's Therapeutic Goods Administration (TGA) has warned about a "rare but severe" eye disorder, non-arteritic anterior ischaemic optic neuropathy (NAION), linked to type 2 diabetes and obesity treatments like Ozempic and Mounjaro. The warning, based on 36 reported cases, advises patients to seek urgent medical attention for sudden vision loss but not to stop treatment without consulting a doctor.
Australia's TGA has issued a safety warning for GLP-1 drugs like Ozempic, Mounjaro, and Wegovy, linking them to non-arteritic anterior ischaemic optic neuropathy (NAION), a rare eye disorder causing potential permanent vision loss. Experts advise caution but not panic, stressing consultation with prescribers.
Um novo estudo com mais de 400 mil mulheres nos EUA revela que a Síndrome Ovariana Metabólica Poliendócrina (SOMP) aumenta em 4,4 vezes o risco de eventos cardiovasculares graves, independentemente de outros fatores de risco. Especialistas reforçam a urgência de monitoramento cardíaco precoce desde o diagnóstico.
Imperial College London experts warn of a "worrying increase" in type 2 diabetes among young women in their 20s in England, linked to rising obesity since the Covid pandemic. Early diagnosis is crucial due to the disease's aggressive nature at a younger age.
Danish pharmaceutical giant Novo Nordisk is suing US-based Eli Lilly in a New Jersey court for "false and misleading" advertisements. Novo Nordisk alleges Eli Lilly used "outdated studies" to compare GLP-1 agonist drugs like Wegovy and Ozempic to Mounjaro and Zepbound, causing confusion.
Novo Nordisk is suing Eli Lilly, alleging "false and misleading" advertisements for its weight-loss and anti-diabetes treatments, Zepbound and Mounjaro. Novo Nordisk claims Lilly used outdated studies comparing its highest doses against lower doses of Novo Nordisk's drugs, creating a deceptive impression of superiority. Eli Lilly defends its ads, citing the Surmount-5 trial as the only direct comparison.
Columbia University research shows chronic, mild sleep deprivation (5-6 hours/night) can lead to weight gain, increased sedentary time, and higher risks for type 2 diabetes and heart disease, challenging modern lifestyles.
Deputy editors of Diabetes Care have released a preprint containing an editorial and seven opinion pieces after the American Diabetes Association refused to publish them. The articles detail new allegations surrounding the removal of five prominent scientists from the ADA's annual meeting in New Orleans for distributing criticism of the Trump administration's attacks on scientific research.
Canetas para emagrecer se tornaram o segundo produto mais apreendido pela Receita Federal na fronteira com o Paraguai, atrás apenas de smartphones. Substâncias como retatrutida, ainda em fase experimental, são vendidas ilegalmente no Brasil, sem registro na Anvisa, apresentando riscos à saúde.
Menino de 10 anos com diabetes foi resgatado após ser encontrado trancado em um apartamento em condições insalubres em Goiânia. A mãe alegou que o mantinha preso para controlar a alimentação, mas a criança não tinha acesso à insulina e vivia em meio a lixo e mau cheiro.
Cardiac surgeon Dr Devi Shetty explains that many heart attacks in India are silent, with nearly 50% of patients having no symptoms, especially diabetics. He emphasizes that feeling healthy doesn't guarantee a healthy heart and urges routine screenings for early detection.
Canetas emagrecedoras contendo retatrutida, substância não aprovada e não comercializável, estão sendo vendidas ilegalmente. Vendedores afirmam que o produto vem dos EUA e não causa efeitos colaterais, mas o fabricante adverte sobre a falta de avaliação regulatória e os riscos à saúde.
New research highlighted by neurologist Dr. Sudhir Kumar suggests nearly one in four adults with type 2 diabetes may have moderate-to-severe hearing loss. This growing evidence indicates diabetes can affect the ears, similar to other organs, prompting calls for early hearing checks.
Vivani Medical is developing a GLP-1 implant for long-term weight loss maintenance, potentially reducing side effects and injection fatigue. The device, an experimental semaglutide implant, aims for twice-yearly or annual administration, complementing existing GLP-1 treatments. However, it faces clinical trials, regulatory hurdles, and questions about cost and physician adoption.
